nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—Ca++ increased—Vandetanib—thyroid cancer	0.0875	0.0875	CcSEcCtD
Cefepime—Calcium low—Vandetanib—thyroid cancer	0.0811	0.0811	CcSEcCtD
Cefepime—Potassium increased—Vandetanib—thyroid cancer	0.0811	0.0811	CcSEcCtD
Cefepime—Blood calcium decreased—Vandetanib—thyroid cancer	0.0484	0.0484	CcSEcCtD
Cefepime—Blood potassium increased—Vandetanib—thyroid cancer	0.0363	0.0363	CcSEcCtD
Cefepime—Pyelonephritis—Vandetanib—thyroid cancer	0.0289	0.0289	CcSEcCtD
Cefepime—Altered state of consciousness—Vandetanib—thyroid cancer	0.0238	0.0238	CcSEcCtD
Cefepime—Hypercalcaemia—Vandetanib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Cefepime—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.0126	0.0126	CcSEcCtD
Cefepime—Septicemia—Epirubicin—thyroid cancer	0.0121	0.0121	CcSEcCtD
Cefepime—Hypocalcaemia—Vandetanib—thyroid cancer	0.012	0.012	CcSEcCtD
Cefepime—Septicemia—Doxorubicin—thyroid cancer	0.0112	0.0112	CcSEcCtD
Cefepime—Depressed level of consciousness—Vandetanib—thyroid cancer	0.0106	0.0106	CcSEcCtD
Cefepime—Colitis—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Cefepime—Sepsis—Vandetanib—thyroid cancer	0.00953	0.00953	CcSEcCtD
Cefepime—Injection site inflammation—Epirubicin—thyroid cancer	0.0082	0.0082	CcSEcCtD
Cefepime—Hypocalcaemia—Sorafenib—thyroid cancer	0.00809	0.00809	CcSEcCtD
Cefepime—Injection site inflammation—Doxorubicin—thyroid cancer	0.00759	0.00759	CcSEcCtD
Cefepime—Neurotoxicity—Epirubicin—thyroid cancer	0.00706	0.00706	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Cefepime—Prothrombin level increased—Epirubicin—thyroid cancer	0.00667	0.00667	CcSEcCtD
Cefepime—Bronchitis—Vandetanib—thyroid cancer	0.00662	0.00662	CcSEcCtD
Cefepime—Neurotoxicity—Doxorubicin—thyroid cancer	0.00653	0.00653	CcSEcCtD
Cefepime—Neutropenia—Vandetanib—thyroid cancer	0.00644	0.00644	CcSEcCtD
Cefepime—Pneumonia—Vandetanib—thyroid cancer	0.00618	0.00618	CcSEcCtD
Cefepime—Prothrombin level increased—Doxorubicin—thyroid cancer	0.00617	0.00617	CcSEcCtD
Cefepime—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00615	0.00615	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00609	0.00609	CcSEcCtD
Cefepime—Renal failure—Vandetanib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Cefepime—Hepatic failure—Sorafenib—thyroid cancer	0.00598	0.00598	CcSEcCtD
Cefepime—Urinary tract infection—Vandetanib—thyroid cancer	0.00597	0.00597	CcSEcCtD
Cefepime—Haemoglobin—Vandetanib—thyroid cancer	0.00554	0.00554	CcSEcCtD
Cefepime—Haemorrhage—Vandetanib—thyroid cancer	0.00551	0.00551	CcSEcCtD
Cefepime—Vaginal moniliasis—Epirubicin—thyroid cancer	0.00542	0.00542	CcSEcCtD
Cefepime—Erythema multiforme—Vandetanib—thyroid cancer	0.00521	0.00521	CcSEcCtD
Cefepime—Vulvovaginal candidiasis—Epirubicin—thyroid cancer	0.0052	0.0052	CcSEcCtD
Cefepime—Vaginal moniliasis—Doxorubicin—thyroid cancer	0.00502	0.00502	CcSEcCtD
Cefepime—Vulvovaginal mycotic infection—Epirubicin—thyroid cancer	0.00501	0.00501	CcSEcCtD
Cefepime—Local reaction—Epirubicin—thyroid cancer	0.00494	0.00494	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Cefepime—Vulvovaginal candidiasis—Doxorubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00474	0.00474	CcSEcCtD
Cefepime—Dysgeusia—Vandetanib—thyroid cancer	0.0047	0.0047	CcSEcCtD
Cefepime—Vulvovaginal mycotic infection—Doxorubicin—thyroid cancer	0.00463	0.00463	CcSEcCtD
Cefepime—Local reaction—Doxorubicin—thyroid cancer	0.00457	0.00457	CcSEcCtD
Cefepime—Neutropenia—Sorafenib—thyroid cancer	0.00434	0.00434	CcSEcCtD
Cefepime—Oral candidiasis—Epirubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Cefepime—Pneumonia—Sorafenib—thyroid cancer	0.00417	0.00417	CcSEcCtD
Cefepime—Convulsion—Vandetanib—thyroid cancer	0.00416	0.00416	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00411	0.00411	CcSEcCtD
Cefepime—Renal failure—Sorafenib—thyroid cancer	0.00407	0.00407	CcSEcCtD
Cefepime—Oral candidiasis—Doxorubicin—thyroid cancer	0.00399	0.00399	CcSEcCtD
Cefepime—Hypercalcaemia—Epirubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Cefepime—Infection—Vandetanib—thyroid cancer	0.00389	0.00389	CcSEcCtD
Cefepime—Thrombocytopenia—Vandetanib—thyroid cancer	0.00383	0.00383	CcSEcCtD
Cefepime—Haemoglobin—Sorafenib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Cefepime—Haemorrhage—Sorafenib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Cefepime—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Cefepime—Paraesthesia—Vandetanib—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cefepime—Erythema multiforme—Sorafenib—thyroid cancer	0.00352	0.00352	CcSEcCtD
Cefepime—Dyspnoea—Vandetanib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Cefepime—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Cefepime—Pain—Vandetanib—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cefepime—Constipation—Vandetanib—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cefepime—Erythema—Sorafenib—thyroid cancer	0.00324	0.00324	CcSEcCtD
Cefepime—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0032	0.0032	CcSEcCtD
Cefepime—Dysgeusia—Sorafenib—thyroid cancer	0.00317	0.00317	CcSEcCtD
Cefepime—Extravasation—Epirubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Cefepime—Vasodilation procedure—Epirubicin—thyroid cancer	0.00311	0.00311	CcSEcCtD
Cefepime—Vasodilation—Epirubicin—thyroid cancer	0.00311	0.00311	CcSEcCtD
Cefepime—Abdominal pain—Vandetanib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Cefepime—Body temperature increased—Vandetanib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Cefepime—Anaemia—Sorafenib—thyroid cancer	0.00299	0.00299	CcSEcCtD
Cefepime—Hypocalcaemia—Epirubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Cefepime—Extravasation—Doxorubicin—thyroid cancer	0.0029	0.0029	CcSEcCtD
Cefepime—Leukopenia—Sorafenib—thyroid cancer	0.0029	0.0029	CcSEcCtD
Cefepime—Vasodilation—Doxorubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Cefepime—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00288	0.00288	CcSEcCtD
Cefepime—Inflammation—Epirubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Cefepime—Pruritus—Vandetanib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Cefepime—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Cefepime—Vaginal inflammation—Epirubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Cefepime—Diarrhoea—Vandetanib—thyroid cancer	0.00268	0.00268	CcSEcCtD
Cefepime—Anaphylactic shock—Sorafenib—thyroid cancer	0.00264	0.00264	CcSEcCtD
Cefepime—Colitis—Epirubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Cefepime—Infection—Sorafenib—thyroid cancer	0.00262	0.00262	CcSEcCtD
Cefepime—Candida infection—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Cefepime—Inflammation—Doxorubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Cefepime—Shock—Sorafenib—thyroid cancer	0.0026	0.0026	CcSEcCtD
Cefepime—Dizziness—Vandetanib—thyroid cancer	0.00259	0.00259	CcSEcCtD
Cefepime—Thrombocytopenia—Sorafenib—thyroid cancer	0.00259	0.00259	CcSEcCtD
Cefepime—Vaginal infection—Epirubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Cefepime—Aplastic anaemia—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Cefepime—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Cefepime—Coma—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Cefepime—Vomiting—Vandetanib—thyroid cancer	0.00249	0.00249	CcSEcCtD
Cefepime—Rash—Vandetanib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Cefepime—Dermatitis—Vandetanib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Cefepime—Headache—Vandetanib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Cefepime—Colitis—Doxorubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Cefepime—Candida infection—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Cefepime—Sepsis—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Cefepime—Dyspnoea—Sorafenib—thyroid cancer	0.00236	0.00236	CcSEcCtD
Cefepime—Nausea—Vandetanib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Cefepime—Coma—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Cefepime—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00228	0.00228	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Cefepime—Pain—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Cefepime—Constipation—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Cefepime—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00216	0.00216	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Cefepime—Urticaria—Sorafenib—thyroid cancer	0.0021	0.0021	CcSEcCtD
Cefepime—Abdominal pain—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefepime—Body temperature increased—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Cefepime—Hypersensitivity—Sorafenib—thyroid cancer	0.00195	0.00195	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Cefepime—Pruritus—Sorafenib—thyroid cancer	0.00187	0.00187	CcSEcCtD
Cefepime—Diarrhoea—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefepime—Dizziness—Sorafenib—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Cefepime—Vomiting—Sorafenib—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cefepime—Rash—Sorafenib—thyroid cancer	0.00167	0.00167	CcSEcCtD
Cefepime—Dermatitis—Sorafenib—thyroid cancer	0.00166	0.00166	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Cefepime—Headache—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Cefepime—Nausea—Sorafenib—thyroid cancer	0.00157	0.00157	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Cefepime—Renal failure—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Cefepime—Chills—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Erythema—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Cefepime—Chills—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Cefepime—Erythema—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Anaemia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Cefepime—Agitation—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cefepime—Convulsion—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Cefepime—Agitation—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—thyroid cancer	0.000991	0.000991	CcSEcCtD
Cefepime—Confusional state—Epirubicin—thyroid cancer	0.000984	0.000984	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—thyroid cancer	0.000976	0.000976	CcSEcCtD
Cefepime—Infection—Epirubicin—thyroid cancer	0.00097	0.00097	CcSEcCtD
Cefepime—Shock—Epirubicin—thyroid cancer	0.000961	0.000961	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—thyroid cancer	0.000959	0.000959	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—thyroid cancer	0.000956	0.000956	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—thyroid cancer	0.000911	0.000911	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000903	0.000903	CcSEcCtD
Cefepime—Infection—Doxorubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Cefepime—Shock—Doxorubicin—thyroid cancer	0.000889	0.000889	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000884	0.000884	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—thyroid cancer	0.000877	0.000877	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Cefepime—Pain—Epirubicin—thyroid cancer	0.000835	0.000835	CcSEcCtD
Cefepime—Constipation—Epirubicin—thyroid cancer	0.000835	0.000835	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—thyroid cancer	0.000811	0.000811	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Cefepime—Urticaria—Epirubicin—thyroid cancer	0.000776	0.000776	CcSEcCtD
Cefepime—Constipation—Doxorubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Cefepime—Pain—Doxorubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—thyroid cancer	0.000772	0.000772	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—thyroid cancer	0.000772	0.000772	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000739	0.000739	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—thyroid cancer	0.000719	0.000719	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—thyroid cancer	0.000718	0.000718	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Cefepime—Pruritus—Epirubicin—thyroid cancer	0.000691	0.000691	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—thyroid cancer	0.000668	0.000668	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—thyroid cancer	0.000666	0.000666	CcSEcCtD
Cefepime—Dizziness—Epirubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—thyroid cancer	0.000639	0.000639	CcSEcCtD
Cefepime—Vomiting—Epirubicin—thyroid cancer	0.000621	0.000621	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—thyroid cancer	0.000618	0.000618	CcSEcCtD
Cefepime—Rash—Epirubicin—thyroid cancer	0.000616	0.000616	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Cefepime—Headache—Epirubicin—thyroid cancer	0.000612	0.000612	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—thyroid cancer	0.000597	0.000597	CcSEcCtD
Cefepime—Nausea—Epirubicin—thyroid cancer	0.00058	0.00058	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—thyroid cancer	0.000574	0.000574	CcSEcCtD
Cefepime—Rash—Doxorubicin—thyroid cancer	0.00057	0.00057	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—thyroid cancer	0.000569	0.000569	CcSEcCtD
Cefepime—Headache—Doxorubicin—thyroid cancer	0.000566	0.000566	CcSEcCtD
Cefepime—Nausea—Doxorubicin—thyroid cancer	0.000537	0.000537	CcSEcCtD
